TARGETING BCL-6 IN DIFFUSE LARGE B-CELL LYMPHOMA: WHAT DOES THIS MEAN FOR THE FUTURE TREATMENT?

Схожие документы

• Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas
  по: Polo, Jose M., et al.
  Опубликовано: (2007)
• Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas
  по: Parekh, Samir S, et al.
  Опубликовано: (2008)
• Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma
  по: Cardenas, Mariano G., et al.
  Опубликовано: (2016)
• Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
  по: Dupont, Thibault, et al.
  Опубликовано: (2015)
• Sequential transcription factor targeting for diffuse large B-cell lymphomas
  по: Cerchietti, Leandro C, et al.
  Опубликовано: (2008)